Sandoz to expand biosimilar manufacturing in Germany
€25m funding is intended to unite a cutting-edge biotech lab and analytical expertise at Sandoz's German biosimilar manufacturing site.
Source: europeanpharmaceuticalreview.com
Stay updated with breaking news from Development Platform Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
€25m funding is intended to unite a cutting-edge biotech lab and analytical expertise at Sandoz's German biosimilar manufacturing site.